Načítá se...
Clinical trial designs for evaluating the medical utility of prognostic and predictive biomarkers in oncology
Physicians need improved tools for selecting treatments for individual patients. Many diagnostic entities hat were traditionally viewed as individual diseases are heterogeneous in their molecular pathogenesis and treatment responsiveness. This results in the treatment of many patients with ineffecti...
Uloženo v:
| Hlavní autor: | |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2010
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2851173/ https://ncbi.nlm.nih.gov/pubmed/20383292 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/pme.09.49 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|